• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓母细胞瘤中特定亚组的免疫和基质微环境

Subgroup-specific immune and stromal microenvironment in medulloblastoma.

作者信息

Bockmayr Michael, Mohme Malte, Klauschen Frederick, Winkler Beate, Budczies Jan, Rutkowski Stefan, Schüller Ulrich

机构信息

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.

出版信息

Oncoimmunology. 2018 May 24;7(9):e1462430. doi: 10.1080/2162402X.2018.1462430. eCollection 2018.

DOI:10.1080/2162402X.2018.1462430
PMID:30228931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6140816/
Abstract

Knowledge on immune and stromal cells in medulloblastoma microenvironment is still limited as previous work was frequently restricted by low sample size and the lack of molecular subgroup information. We characterized 10 microenvironment cell populations as well as from gene expression in 1422 brain tumors and 763 medulloblastomas. All in all, medulloblastomas showed low expression of immune markers. Still, there were substantial differences with a clustering of medulloblastoma subgroups according to their microenvironment profile. Specifically, SHH medulloblastomas displayed strong signatures of fibroblasts, T cells and macrophages, while markers of cytotoxic lymphocytes were enriched in Group 4 tumors. gene expression appeared to be relatively high in single SHH and WNT cases but was undetectable by immunohistochemistry. In addition, two diverse immuno-stromal patterns were identified, indicating distinct types of local tumor immunosuppression, which were primarily controlled by either macrophage and regulatory T cell-mediated mechanisms or immunosuppressive cytokines and checkpoints, respectively. None of the immune cell signatures had an independent prognostic value in the present dataset after multiple testing correction. These results suggest a mild, but subgroup-specific infiltration of immune cells in medulloblastoma.

摘要

由于先前的研究常常受到样本量小和缺乏分子亚组信息的限制,因此对髓母细胞瘤微环境中免疫细胞和基质细胞的了解仍然有限。我们根据1422例脑肿瘤和763例髓母细胞瘤的基因表达情况,对10种微环境细胞群进行了特征分析。总体而言,髓母细胞瘤的免疫标志物表达较低。不过,根据其微环境特征,髓母细胞瘤亚组之间仍存在显著差异。具体而言,SHH髓母细胞瘤表现出成纤维细胞、T细胞和巨噬细胞的强烈特征,而细胞毒性淋巴细胞的标志物在4组肿瘤中富集。在单个SHH和WNT病例中,[此处原文缺失相关基因名称]基因表达似乎相对较高,但免疫组化检测不到。此外,还确定了两种不同的免疫-基质模式,表明存在不同类型的局部肿瘤免疫抑制,它们分别主要由巨噬细胞和调节性T细胞介导的机制或免疫抑制细胞因子和检查点控制。在进行多次检验校正后,本数据集中没有一种免疫细胞特征具有独立的预后价值。这些结果表明,髓母细胞瘤中存在轻度但亚组特异性的免疫细胞浸润。

相似文献

1
Subgroup-specific immune and stromal microenvironment in medulloblastoma.髓母细胞瘤中特定亚组的免疫和基质微环境
Oncoimmunology. 2018 May 24;7(9):e1462430. doi: 10.1080/2162402X.2018.1462430. eCollection 2018.
2
Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets.成神经管细胞瘤中免疫检查点基因的数字表达谱鉴定 CD24 和 CD276 为潜在的免疫治疗靶点。
Front Immunol. 2023 Feb 7;14:1062856. doi: 10.3389/fimmu.2023.1062856. eCollection 2023.
3
Immune cell infiltration and cytokine secretion analysis reveal a non-inflammatory microenvironment of medulloblastoma.免疫细胞浸润和细胞因子分泌分析揭示了髓母细胞瘤的非炎症微环境。
Oncol Lett. 2020 Dec;20(6):397. doi: 10.3892/ol.2020.12260. Epub 2020 Oct 29.
4
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma.小儿髓母细胞瘤中肿瘤浸润淋巴细胞和免疫检查点的预后相关性
Oncoimmunology. 2017 Nov 27;7(3):e1398877. doi: 10.1080/2162402X.2017.1398877. eCollection 2018.
5
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.髓母细胞瘤中 TP53 突变的亚组特异性预后意义。
J Clin Oncol. 2013 Aug 10;31(23):2927-35. doi: 10.1200/JCO.2012.48.5052. Epub 2013 Jul 8.
6
Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors.甲基化图谱中的性别差异在髓母细胞瘤中很明显,尤其是在SHH肿瘤中。
Front Oncol. 2023 Mar 24;13:1113121. doi: 10.3389/fonc.2023.1113121. eCollection 2023.
7
New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.深入了解富含淋巴细胞基质的胃癌炎症肿瘤免疫微环境:从形态学和数字分析到基因表达。
Gastric Cancer. 2019 Jan;22(1):77-90. doi: 10.1007/s10120-018-0836-8. Epub 2018 May 19.
8
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.低级别、早期子宫内膜癌患者肿瘤免疫微环境与临床结局的相关性。
J Pathol. 2022 Dec;258(4):426-436. doi: 10.1002/path.6012. Epub 2022 Oct 25.
9
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.TERT 启动子突变在 SHH 亚组髓母细胞瘤中高度复发。
Acta Neuropathol. 2013 Dec;126(6):917-29. doi: 10.1007/s00401-013-1198-2. Epub 2013 Oct 31.
10
Medulloblastoma comprises four distinct molecular variants.髓母细胞瘤包含四个不同的分子亚型。
J Clin Oncol. 2011 Apr 10;29(11):1408-14. doi: 10.1200/JCO.2009.27.4324. Epub 2010 Sep 7.

引用本文的文献

1
Direct oHSV Infection Induces DC Maturation and a Tumor Therapeutic Response.单纯疱疹病毒直接感染诱导树突状细胞成熟及肿瘤治疗反应。
Viruses. 2025 Aug 19;17(8):1134. doi: 10.3390/v17081134.
2
Advancing Medulloblastoma Therapy in Pediatrics: Integrative Molecular Classification and Emerging Treatments.推进儿童髓母细胞瘤治疗:综合分子分类与新兴疗法
Brain Sci. 2025 Aug 21;15(8):896. doi: 10.3390/brainsci15080896.
3
Dual targeting of / and / immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastoma.对/和/免疫检查点的双重靶向增强了髓母细胞瘤中自然杀伤细胞介导的细胞毒性。
Neurooncol Adv. 2025 May 18;7(1):vdaf099. doi: 10.1093/noajnl/vdaf099. eCollection 2025 Jan-Dec.
4
Medulloblastoma: biology and immunotherapy.髓母细胞瘤:生物学与免疫疗法
Front Immunol. 2025 Jul 3;16:1602930. doi: 10.3389/fimmu.2025.1602930. eCollection 2025.
5
CD4 T cells correlate with better prognosis in medulloblastoma.在髓母细胞瘤中,CD4 T细胞与较好的预后相关。
Front Oncol. 2025 Jun 12;15:1593329. doi: 10.3389/fonc.2025.1593329. eCollection 2025.
6
Tumor-associated macrophages correlate with better outcome in SHH medulloblastoma.肿瘤相关巨噬细胞与SHH型髓母细胞瘤的较好预后相关。
Front Oncol. 2025 Apr 15;15:1557313. doi: 10.3389/fonc.2025.1557313. eCollection 2025.
7
Characterization of immune microenvironment associated with medulloblastoma metastasis based on explainable machine learning.基于可解释机器学习的髓母细胞瘤转移相关免疫微环境特征分析
Pediatr Investig. 2025 Feb 14;9(1):59-69. doi: 10.1002/ped4.12471. eCollection 2025 Mar.
8
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.EphA2和磷酸抗原介导的γδT细胞对髓母细胞瘤的选择性杀伤可保持神经元和干细胞的完整性。
Oncoimmunology. 2025 Dec;14(1):2485535. doi: 10.1080/2162402X.2025.2485535. Epub 2025 Apr 7.
9
Orlistat facilitates immunotherapy via AKT-FOXO3a-FOXM1-mediated PD-L1 suppression.奥利司他通过AKT-FOXO3a-FOXM1介导的PD-L1抑制促进免疫治疗。
J Immunother Cancer. 2025 Mar 26;13(3):e008923. doi: 10.1136/jitc-2024-008923.
10
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics.基于整合多组学技术绘制髓母细胞瘤中自然呈现的T细胞抗原图谱。
Nat Commun. 2025 Feb 4;16(1):1364. doi: 10.1038/s41467-025-56268-0.

本文引用的文献

1
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.WNT/β-catenin 通路激活与人类癌症中的免疫排斥相关。
Clin Cancer Res. 2019 May 15;25(10):3074-3083. doi: 10.1158/1078-0432.CCR-18-1942. Epub 2019 Jan 11.
2
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma.小儿髓母细胞瘤中肿瘤浸润淋巴细胞和免疫检查点的预后相关性
Oncoimmunology. 2017 Nov 27;7(3):e1398877. doi: 10.1080/2162402X.2017.1398877. eCollection 2018.
3
Immunotherapies for malignant glioma.恶性脑胶质瘤的免疫治疗。
Oncogene. 2018 Mar;37(9):1121-1141. doi: 10.1038/s41388-017-0024-z. Epub 2017 Dec 15.
4
The whole-genome landscape of medulloblastoma subtypes.髓母细胞瘤亚型的全基因组图谱。
Nature. 2017 Jul 19;547(7663):311-317. doi: 10.1038/nature22973.
5
Immune classifications with cytotoxic CD8 and Th17 infiltrates are predictors of clinical prognosis in glioblastoma.具有细胞毒性CD8和Th17浸润的免疫分类是胶质母细胞瘤临床预后的预测指标。
Oncoimmunology. 2017 Apr 28;6(6):e1321186. doi: 10.1080/2162402X.2017.1321186. eCollection 2017.
6
Immunotherapy for Brain Tumors.脑肿瘤的免疫治疗。
J Clin Oncol. 2017 Jul 20;35(21):2450-2456. doi: 10.1200/JCO.2017.72.8089. Epub 2017 Jun 22.
7
Intertumoral Heterogeneity within Medulloblastoma Subgroups.髓母细胞瘤亚组内的肿瘤间异质性。
Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005.
8
Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.评估小儿癌症组织中的程序性死亡配体 1 表达和肿瘤相关免疫细胞。
Cancer. 2017 Oct 1;123(19):3807-3815. doi: 10.1002/cncr.30724. Epub 2017 Jun 13.
9
Wnt/beta-catenin pathway: modulating anticancer immune response.Wnt/β-连环蛋白信号通路:调节抗癌免疫反应。
J Hematol Oncol. 2017 May 5;10(1):101. doi: 10.1186/s13045-017-0471-6.
10
High programmed cell death 1 ligand-1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma.高程序性细胞死亡配体 1 表达:与人类髓母细胞瘤中 CD8+ T 细胞浸润和不良预后相关。
J Neurosurg. 2018 Mar;128(3):710-716. doi: 10.3171/2016.11.JNS16991. Epub 2017 May 5.